Pfizer asks FDA to approve omicron-specific booster shot
Aug 22, 2022
The drug company says that its new mRNA vaccine produces an immune response against the BA.4 and BA.5 omicron subvariants.
Alzheimer’s blood biomarkers not ready for primary care use, expert panel decides
By
Alicia Lasek
Aug 18, 2022
An international group of clinicians and researchers have agreed that Alzheimer’s disease blood biomarkers are a significant breakthrough, but are not yet ready for general clinical and primary care...
Variant-adapted COVID shot approved in U.K.; Novavax requests U.S. booster nod
By
Alicia Lasek
Aug 16, 2022
Novavax wants its U.S. vaccine authorization to extend to a booster shot, and the U.K. has approved a two-component vaccine that directly tackles the omicron variant.
CDC extends free COVID-19 PCR testing program to assisted living
By
Kimberly Bonvissuto
Aug 07, 2022
Assisted living communities now have access to free COVID-19 testing through a federal program that previously targeted schools, shelters and correctional facilities.
FDA nixes use of Parkinson’s drug Nuplazid for treating Alzheimer’s psychosis
By
Alicia Lasek
Aug 08, 2022
The Food and Drug Administration has decided not to approve an expanded use of the psychosis drug pimavanserin (Nuplazid) to treat patients with Alzheimer’s.
ADA: Diabetes may quadruple risk for long COVID
Jun 08, 2022
Diabetes may increase the risk for long COVID symptoms fourfold, according to research presented at the annual meeting of the American Diabetes Association.
Aduhelm’s costs: Medicare recipients won’t get premium reduction until 2023
By
Alicia Lasek (f3)
Jun 01, 2022
A cost overestimate that bumped up Medicare premiums for seniors in 2022 will not be corrected until the following year. The spike is tied to coverage for Alzheimer’s drug Aduhelm.
Burden of persistent symptoms high after COVID-19 infection
May 24, 2022
– A high burden of persistent symptoms is observed in persons after COVID-19, but no specific causes of symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)...
AHCA/NCAL, 15 other groups pressure HHS to extend public health emergency
By
Lois A. Bowers
May 12, 2022
Sixteen national organizations were thinking of fall and the flu Tuesday when they asked HHS Secretary Xavier Becerra to extend the public health emergency related to COVID-19.
LeadingAge’s president and CEO has asked Congress to ensure access to COVID-19 tests, vaccines and treatments in letters supporting the White House’s request for COVID-19 supplemental funds.